Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Summary
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Official title: A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-06-26
Completion Date
2028-02-04
Last Updated
2026-03-12
Healthy Volunteers
No
Interventions
MT-501
MT-501
MT-201
MT-201
Locations (66)
Mirador Therapeutics Selected Site
Birmingham, Alabama, United States
Mirador Therapeutics Selected Site
Scottsdale, Arizona, United States
Mirador Therapeutics Selected Site
Sun City, Arizona, United States
Mirador Therapeutics Selected Site
Little Rock, Arkansas, United States
Mirador Therapeutics Selected Site
Little Rock, Arkansas, United States
Mirador Therapeutics Selected Site
Colorado Springs, Colorado, United States
Mirador Therapeutics Selected Site
Littleton, Colorado, United States
Mirador Therapeutics Selected Site
Miami, Florida, United States
Mirador Therapeutics Selected Site
Miami, Florida, United States
Mirador Therapeutics Selected Site
Miami, Florida, United States
Mirador Therapeutics Selected Site
Orlando, Florida, United States
Mirador Therapeutics Selected Site
Palmetto Bay, Florida, United States
Mirador Therapeutics Selected Site
Pensacola, Florida, United States
Mirador Therapeutics Selected Site
Atlanta, Georgia, United States
Mirador Therapeutics Selected Site
Snellville, Georgia, United States
Mirador Therapeutics Selected Site
Glenview, Illinois, United States
Mirador Therapeutics Selected Site
Gurnee, Illinois, United States
Mirador Therapeutics Selected Site
Lafayette, Louisiana, United States
Mirador Therapeutics Selected Site
Marrero, Louisiana, United States
Mirador Therapeutics Selected Site
Shreveport, Louisiana, United States
Mirador Therapeutics Selected Site
Ypsilanti, Michigan, United States
Mirador Therapeutics Selected Site
Bridgeton, Missouri, United States
Mirador Therapeutics Selected Site
Kansas City, Missouri, United States
Mirador Therapeutics Selected Site
Liberty, Missouri, United States
Mirador Therapeutics Selected Site
Las Vegas, Nevada, United States
Mirador Therapeutics Selected Site
New York, New York, United States
Mirador Therapeutics Selected Site
Rochester, New York, United States
Mirador Therapeutics Selected Site
High Point, North Carolina, United States
Mirador Therapeutics Selected Site
Raleigh, North Carolina, United States
Mirador Therapeutics Selected Site
Cincinnati, Ohio, United States
Mirador Therapeutics Selected Site
Liberty Township, Ohio, United States
Mirador Therapeutics Selected Site
Providence, Rhode Island, United States
Mirador Therapeutics Selected Site
Greenville, South Carolina, United States
Mirador Therapeutics Selected Site
Cordova, Tennessee, United States
Mirador Therapeutics Selected Site
Dallas, Texas, United States
Mirador Therapeutics Selected Site
Garland, Texas, United States
Mirador Therapeutics Selected Site
Georgetown, Texas, United States
Mirador Therapeutics Selected Site
Houston, Texas, United States
Mirador Therapeutics Selected Site
Lubbock, Texas, United States
Mirador Therapeutics Selected Site
Southlake, Texas, United States
Mirador Therapeutics Selected Site
Tyler, Texas, United States
Mirador Therapeutics Selected Site
Webster, Texas, United States
Mirador Therapeutics Selected Site
Bellevue, Washington, United States
Mirador Therapeutics Selected Site
Silverdale, Washington, United States
Mirador Therapeutics Selected Site
Tacoma, Washington, United States
Mirador Therapeutics Selected Site
Milwaukee, Wisconsin, United States
Mirador Therapeutics Selected Site
Toronto, Canada
Mirador Therapeutics Selected Site
Kutaisi, Georgia
Mirador Therapeutics Selected Site
Marneuli, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Tbilisi, Georgia
Mirador Therapeutics Selected Site
Chisinau, Moldova
Mirador Therapeutics Selected Site
Chisinau, Moldova
Mirador Therapeutics Selected Site
Ivano-Frankivsk, Ukraine
Mirador Therapeutics Selected Site
Kyiv, Ukraine
Mirador Therapeutics Selected Site
Kyiv, Ukraine
Mirador Therapeutics Selected Site
Kyiv, Ukraine
Mirador Therapeutics Selected Site
Kyiv, Ukraine
Mirador Therapeutics Selected Site
Lutsk, Ukraine
Mirador Therapeutics Selected Site
Lviv, Ukraine
Mirador Therapeutics Selected Site
Poltava, Ukraine
Mirador Therapeutics Selected Site
Vinnytsia, Ukraine